Compare Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF (PDBC) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF vs Tenet Healthcare Corporation — how do they compare? Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF trades at $19.66 (market cap $7.77B), while Tenet Healthcare Corporation trades at $264.27 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 2.7× Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF's market cap, and Tenet Healthcare Corporation is more actively traded (428,008 versus 6,100,303). Which is the better fit depends on your goals — on Pluang, investors hold Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF for 56 Days and Tenet Healthcare Corporation for 15 Days on average.
| PDBC | THC | |
|---|---|---|
Market Cap | $7.77B | $20.98B |
Volume | 6,100,303 | 428,008 |
52-Week High | $20.10 | $280.77 |
52-Week Low | $13.16 | $161.37 |
Typical Hold Time | 56 Days | 15 Days |
Sector | — | Health |
Enterprise Value | — | $32.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PDBC (Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF) trades at $19.66, up 1.29% with strong bullish technical signals from moving averages. The ETF has delivered impressive performance with 45.66% year-to-date gains through Q3 2026, driven by energy and agricultural commodity strength amid geopolitical tensions. Recent institutional activity shows mixed sentiment with significant short interest growth of 215.4% in September offset by multiple institutional purchases.
The commodity ETF outlook remains positive given ongoing geopolitical risks and defensive sector rotation, though elevated short interest and overbought RSI readings suggest near-term consolidation risk. Commodity super-squeeze warnings from HSBC highlight potential upside while defensive ETF inflows support continued institutional demand.
Tenet Healthcare (THC) trades at $263.78, up 1.52% today, with a bullish technical signal from moving averages and strong fundamental support. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 29, 2026. Revenue grew to $21.31B in 2025, with a robust net income margin of 9.9% and high return on equity of 53.31%, while valuation ratios like P/E of 10.07 and EV/EBITDA of 5.75 suggest potential undervaluation.
The outlook is positive, driven by earnings momentum and analyst consensus favoring buys, with a price target of $283.36 offering upside. Risks include reliance on surgical volumes and capital return sustainability, but strong cash flow and efficiency gains support growth. Investors should weigh solid fundamentals against sector-specific headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF
The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing in a combination of financial instruments that are economically linked to the world's most heavily traded commodities. Commodities are assets that have tangible properties, such as oil, agricultural produce or raw metals.
Read more on PDBC →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
